Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
J.Molner ASOTSE:MOLNR 40 Current Ratio is 0.93 as of Dec. 2025, which is 15% above its 10-year median of 0.81. GuruFocus rates OTSE:MOLNR with a GF Score™ of 40/100 and a GF Value™ of €19.63 (Fairly Valued). The stock has 7 warning signs investors should review. Among 996 Drug Manufacturers companies, J.Molner AS ranks worse than 85.04% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. J.Molner AS's current ratio for the quarter that ended in Dec. 2025 was 0.93.
J.Molner AS has a current ratio of 0.93. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If J.Molner AS has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for J.Molner AS's Current Ratio or its related term are showing as below:
OTSE:MOLNR'
s Current Ratio Range Over the Past 10 Years
Min: 0.5 Med: 0.81 Max: 1.76
Current: 0.93
During the past 5 years, J.Molner AS's highest Current Ratio was 1.76. The lowest was 0.50. And the median was 0.81.
OTSE:MOLNR's Current Ratio is ranked worse than 85.04% of 996
companies
in the Drug Manufacturers industry
Industry Median: 1.92
vs OTSE:MOLNR: 0.93
J.Molner AS (OTSE:MOLNR) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
J.Molner AS Current Ratio Related Terms
J.Molner AS Current Ratio Historical Data
* Premium members only.
The historical data trend for J.Molner AS's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OTSE:MOLNR vs ZTS, UTHR, VTRS: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, J.Molner AS's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
J.Molner AS Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, J.Molner AS's Current Ratio distribution charts can be found below:
* The bar in red indicates where J.Molner AS's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
J.Molner AS (OTSE:MOLNR) has a Current Ratio of 0.93 as of Dec. 2025. This is 15% above median its historical median of 0.81. Over the past decade, J.Molner AS's Current Ratio has ranged from 0.50 to 1.76. According to the industry distribution chart, J.Molner AS ranks #847 out of 996 companies in the Drug Manufacturers industry, placing it in the top 85%.
Is J.Molner AS's Current Ratio too high?
J.Molner AS's current Current Ratio of 0.93 is 15% above median its 10-year median of 0.81. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 1.76. The Drug Manufacturers industry median Current Ratio is 1.92. J.Molner AS's value of 0.93 is 51.6% below this industry median. Based on the distribution chart, J.Molner AS ranks #847 out of 996 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, J.Molner AS has a GF Score™ of 40/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does J.Molner AS's Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, J.Molner AS ranks #847 out of 996 companies for Current Ratio. This places J.Molner AS in the lower half of its industry. The industry median Current Ratio is 1.92. J.Molner AS's value of 0.93 is 51.6% below this benchmark. Historically, J.Molner AS's own Current Ratio has ranged from 0.50 to 1.76 over the past decade. While the company's 10-year median is 0.81 vs. the industry median of 1.92, J.Molner AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 1.92, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. J.Molner AS's current Current Ratio of 0.93 is 51.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. J.Molner AS's current Current Ratio is 0.93, which is 15% above median its own 10-year median of 0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J.Molner AS stock overvalued right now?
Based on GuruFocus' analysis, J.Molner AS (OTSE:MOLNR) is currently considered Fairly Valued. The stock's GF Value™ is €19.63, compared to a current price of €18.90 — trading 3.7% below its estimated fair value. The current Current Ratio is 0.93, which is 15% above median its 10-year median of 0.81 and 51.6% below the Drug Manufacturers industry median of 1.92. J.Molner AS's overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For J.Molner AS (OTSE:MOLNR), the current Current Ratio is 0.93 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is J.Molner AS (OTSE:MOLNR) Overvalued in 2026?
Based on GuruFocus' analysis, J.Molner AS stock appears to be undervalued.
The current stock price of €18.90 is trading 3.7% below its estimated GF Value™ of €19.63.
GuruFocus considers J.Molner AS to be Fairly Valued.
Key valuation signals for OTSE:MOLNR:
Current Ratio: 0.93 (15% above median its 10-year median of 0.81)
GF Value™: €19.63 vs. price of €18.90 (3.7% below fair value)
Industry Position: 51.6% below the Drug Manufacturers median (#847 of 996)
No single metric tells the full story. See the OTSE:MOLNR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
J.Molner AS is an Estonia-based company engaged in research and development in the field of biotechnology. It is developing a portfolio of generic drug products for the United States and Canadian markets, consisting of both in-house developed medicines and acquired and in-licensed products. It operates through two complementary business units: internal generic drug development and specialized pharmaceutical services. It develops and commercializes sterile injectable, ophthalmic, and dermatology generic drugs, while also providing drug development services, analytical chemistry and stability testing. Its activities are divided into two business segments, Generic Drugs and Services, with Services generating maximum revenue. The Company generates maximum revenue from the United States.
40GF Score
Get the complete analysis for OTSE:MOLNR
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OTSE:MOLNR has been successfully added to your 
